Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity	FUT3 FUT4 FUT6	1.56e-05	6	186	3	GO:0017083
GeneOntologyMolecularFunction	hexosyltransferase activity	HEXA HEXB POGLUT3 B3GNT5 UGT3A1 CHPF GALNTL6 FUT3 FUT4 FUT6	2.98e-05	211	186	10	GO:0016758
GeneOntologyMolecularFunction	alpha-(1->3)-fucosyltransferase activity	FUT3 FUT4 FUT6	4.30e-05	8	186	3	GO:0046920
GeneOntologyMolecularFunction	glycosyltransferase activity	HEXA HEXB POGLUT3 B3GNT5 UGT3A1 XYLT2 CHPF GALNTL6 FUT3 FUT4 FUT6	8.53e-05	288	186	11	GO:0016757
GeneOntologyMolecularFunction	histone deacetylase inhibitor activity	UCN SKI	8.63e-05	2	186	2	GO:0046811
GeneOntologyMolecularFunction	UDP-glycosyltransferase activity	HEXA HEXB POGLUT3 B3GNT5 UGT3A1 XYLT2 CHPF GALNTL6	9.55e-05	153	186	8	GO:0008194
GeneOntologyMolecularFunction	fucosyltransferase activity	FUT3 FUT4 FUT6	2.68e-04	14	186	3	GO:0008417
GeneOntologyMolecularFunction	hydrolase activity, hydrolyzing O-glycosyl compounds	HEXA HEXB NAGLU IDUA EDEM3 MAN1B1	4.08e-04	103	186	6	GO:0004553
GeneOntologyMolecularFunction	hexosaminidase activity	HEXA HEXB NAGLU	4.91e-04	17	186	3	GO:0015929
GeneOntologyBiologicalProcess	dermatan sulfate catabolic process	HEXA HEXB IDUA	6.89e-06	5	184	3	GO:0030209
GeneOntologyBiologicalProcess	glycoprotein metabolic process	HEXA HEXB POGLUT3 B3GNT5 NAGLU XYLT2 CHPF GALNTL6 NECAB2 IDUA EDEM3 FUT3 FUT4 FUT6 MAN1B1	7.73e-06	430	184	15	GO:0009100
GeneOntologyBiologicalProcess	oligosaccharide metabolic process	HEXB IDUA FUT3 FUT4 FUT6 MAN1B1	3.79e-05	70	184	6	GO:0009311
GeneOntologyBiologicalProcess	glycosphingolipid metabolic process	HEXA HEXB B3GNT5 NAGLU FUT4 FUT6	4.82e-05	73	184	6	GO:0006687
GeneOntologyBiologicalProcess	dermatan sulfate metabolic process	HEXA HEXB IDUA	8.00e-05	10	184	3	GO:0030205
GeneOntologyBiologicalProcess	adult walking behavior	HEXA DMRT3 CNTN2 IDUA EPHA4	8.19e-05	50	184	5	GO:0007628
GeneOntologyBiologicalProcess	glycolipid metabolic process	HEXA HEXB B3GNT5 NAGLU SCCPDH FUT4 FUT6	9.69e-05	119	184	7	GO:0006664
GeneOntologyBiologicalProcess	liposaccharide metabolic process	HEXA HEXB B3GNT5 NAGLU SCCPDH FUT4 FUT6	1.02e-04	120	184	7	GO:1903509
GeneOntologyCellularComponent	beta-N-acetylhexosaminidase complex	HEXA HEXB	8.05e-05	2	188	2	GO:1905379
Domain	fn3	SPEG OBSCN DCC HCFC2 SDK1 CNTN2 ROBO4 COL7A1 FN1 IGDCC3 RIMBP2 EPHA4	6.83e-08	162	183	12	PF00041
Domain	FN3	SPEG OBSCN DCC HCFC2 SDK1 CNTN2 ROBO4 COL7A1 FN1 IGDCC3 RIMBP3 RIMBP2 EPHA4	8.47e-08	199	183	13	PS50853
Domain	FN3_dom	SPEG OBSCN DCC HCFC2 SDK1 CNTN2 ROBO4 COL7A1 FN1 IGDCC3 RIMBP3 RIMBP2 EPHA4	1.50e-07	209	183	13	IPR003961
Domain	FN3	SPEG OBSCN DCC HCFC2 SDK1 CNTN2 ROBO4 COL7A1 FN1 IGDCC3 RIMBP2 EPHA4	2.92e-07	185	183	12	SM00060
Domain	Ig-like_fold	A1BG SLAMF8 POGLUT3 SPEG OSCAR OBSCN DCC NCR3LG1 AMIGO3 SIGLEC10 NECTIN4 HCFC2 SDK1 IGLON5 PLXNA2 CNTN2 ROBO4 COL7A1 FN1 IGDCC3 RIMBP3 RIMBP2 EPHA4	4.48e-07	706	183	23	IPR013783
Domain	-	A1BG POGLUT3 SPEG OSCAR OBSCN DCC NCR3LG1 AMIGO3 SIGLEC10 NECTIN4 HCFC2 SDK1 IGLON5 PLXNA2 CNTN2 ROBO4 COL7A1 FN1 IGDCC3 RIMBP3 RIMBP2 EPHA4	5.98e-07	663	183	22	2.60.40.10
Domain	IGc2	A1BG SPEG OBSCN DCC AMIGO3 SIGLEC10 NECTIN4 SDK1 IGLON5 CNTN2 ROBO4 IGDCC3	3.65e-06	235	183	12	SM00408
Domain	Ig_sub2	A1BG SPEG OBSCN DCC AMIGO3 SIGLEC10 NECTIN4 SDK1 IGLON5 CNTN2 ROBO4 IGDCC3	3.65e-06	235	183	12	IPR003598
Domain	Glyco_transf_10	FUT3 FUT4 FUT6	5.00e-05	8	183	3	PF00852
Domain	Glyco_tran_10_N	FUT3 FUT4 FUT6	5.00e-05	8	183	3	PF17039
Domain	Glyco_tran_10_N	FUT3 FUT4 FUT6	5.00e-05	8	183	3	IPR031481
Domain	Glyco_trans_10	FUT3 FUT4 FUT6	5.00e-05	8	183	3	IPR001503
Domain	IG	A1BG SPEG OSCAR OBSCN DCC NCR3LG1 AMIGO3 SIGLEC10 NECTIN4 SDK1 IGLON5 CNTN2 ROBO4 IGDCC3	7.23e-05	421	183	14	SM00409
Domain	Ig_sub	A1BG SPEG OSCAR OBSCN DCC NCR3LG1 AMIGO3 SIGLEC10 NECTIN4 SDK1 IGLON5 CNTN2 ROBO4 IGDCC3	7.23e-05	421	183	14	IPR003599
Domain	Glycohydro_20b2	HEXA HEXB	9.55e-05	2	183	2	PF14845
Domain	-	HEXA HEXB	9.55e-05	2	183	2	3.30.379.10
Domain	Beta_hexosaminidase_sua/sub	HEXA HEXB	9.55e-05	2	183	2	IPR025705
Domain	HEX_eukaryotic_N	HEXA HEXB	9.55e-05	2	183	2	IPR029019
Domain	Chitobiase/Hex_dom_2-like	HEXA HEXB	9.55e-05	2	183	2	IPR029018
Domain	IG_LIKE	A1BG SLAMF8 SPEG OSCAR OBSCN DCC NCR3LG1 AMIGO3 SIGLEC10 NECTIN4 SDK1 IGLON5 CNTN2 ROBO4 IGDCC3	1.03e-04	491	183	15	PS50835
Domain	Ig_I-set	SPEG OBSCN DCC SIGLEC10 SDK1 IGLON5 CNTN2 ROBO4 IGDCC3	1.10e-04	190	183	9	IPR013098
Domain	I-set	SPEG OBSCN DCC SIGLEC10 SDK1 IGLON5 CNTN2 ROBO4 IGDCC3	1.10e-04	190	183	9	PF07679
Domain	-	DAB2IP OBSCN PHLDB1 DNM1 PLEKHA7 VASP APBB1 TRIOBP PLEKHA6 PTPN21 SH2B1 ARHGEF39 GAB3	1.32e-04	391	183	13	2.30.29.30
Domain	Ig-like_dom	A1BG SLAMF8 SPEG OSCAR OBSCN DCC NCR3LG1 AMIGO3 SIGLEC10 NECTIN4 SDK1 IGLON5 CNTN2 ROBO4 IGDCC3	1.34e-04	503	183	15	IPR007110
Domain	EGF_LAM_2	LAMA1 NTN5 LAMA5 ATRNL1	2.00e-04	30	183	4	PS50027
Domain	EGF_LAM_1	LAMA1 NTN5 LAMA5 ATRNL1	2.00e-04	30	183	4	PS01248
Domain	Glyco_hydro_20_cat	HEXA HEXB	2.85e-04	3	183	2	IPR015883
Domain	Glyco_hydro_20	HEXA HEXB	2.85e-04	3	183	2	PF00728
Domain	Stereocilin-rel	STRC OTOA	2.85e-04	3	183	2	IPR026664
Domain	PH_dom-like	DAB2IP OBSCN PHLDB1 DNM1 PLEKHA7 VASP APBB1 TRIOBP PLEKHA6 PTPN21 SH2B1 ARHGEF39 GAB3	3.03e-04	426	183	13	IPR011993
Domain	EGF_Lam	LAMA1 NTN5 LAMA5 ATRNL1	3.68e-04	35	183	4	SM00180
Domain	PH	DAB2IP OBSCN PHLDB1 DNM1 PLEKHA7 TRIOBP PLEKHA6 SH2B1 ARHGEF39 GAB3	4.29e-04	278	183	10	SM00233
Domain	PH_DOMAIN	DAB2IP OBSCN PHLDB1 DNM1 PLEKHA7 TRIOBP PLEKHA6 SH2B1 ARHGEF39 GAB3	4.42e-04	279	183	10	PS50003
Domain	PH_domain	DAB2IP OBSCN PHLDB1 DNM1 PLEKHA7 TRIOBP PLEKHA6 SH2B1 ARHGEF39 GAB3	4.54e-04	280	183	10	IPR001849
Domain	Laminin_EGF	LAMA1 NTN5 LAMA5 ATRNL1	5.07e-04	38	183	4	IPR002049
Domain	SOCS	WSB1 CISH ASB2	9.33e-04	20	183	3	SM00253
Domain	Laminin_domII	LAMA1 LAMA5	9.36e-04	5	183	2	IPR010307
Domain	TMEM132D_N	TMEM132C TMEM132A	9.36e-04	5	183	2	PF15705
Domain	TMEM132D_C	TMEM132C TMEM132A	9.36e-04	5	183	2	PF15706
Domain	TMEM132_M	TMEM132C TMEM132A	9.36e-04	5	183	2	IPR031437
Domain	TMEM132_C	TMEM132C TMEM132A	9.36e-04	5	183	2	IPR031436
Domain	TMEM132_N	TMEM132C TMEM132A	9.36e-04	5	183	2	IPR031435
Domain	TMEM132	TMEM132C TMEM132A	9.36e-04	5	183	2	IPR026307
Domain	TMEM132	TMEM132C TMEM132A	9.36e-04	5	183	2	PF16070
Domain	Laminin_aI	LAMA1 LAMA5	9.36e-04	5	183	2	IPR009254
Domain	Laminin_I	LAMA1 LAMA5	9.36e-04	5	183	2	PF06008
Domain	Laminin_II	LAMA1 LAMA5	9.36e-04	5	183	2	PF06009
Domain	EGF_1	LAMA1 GAS6 MEP1A BMP1 NTN5 FN1 LAMA5 ATRNL1 LTBP2	9.48e-04	255	183	9	PS00022
Domain	-	KBTBD11 HCFC2 ATRNL1 KLHDC8A	1.24e-03	48	183	4	2.120.10.80
Domain	Peptidase_M12A	MEP1A BMP1	1.40e-03	6	183	2	IPR001506
Domain	Astacin	MEP1A BMP1	1.40e-03	6	183	2	PF01400
Domain	Glycoside_hydrolase_SF	HEXA HEXB NAGLU IDUA	1.80e-03	53	183	4	IPR017853
Domain	PH	OBSCN PHLDB1 DNM1 PLEKHA7 TRIOBP PLEKHA6 SH2B1 GAB3	1.93e-03	229	183	8	PF00169
Domain	Glyco_hydro_47	EDEM3 MAN1B1	1.94e-03	7	183	2	PF01532
Domain	-	EDEM3 MAN1B1	1.94e-03	7	183	2	1.50.10.50
Domain	Kelch-typ_b-propeller	KBTBD11 HCFC2 ATRNL1 KLHDC8A	2.06e-03	55	183	4	IPR015915
Pathway	KEGG_MEDICUS_REFERENCE_LEWIS_X_ANTIGEN_BIOSYNTHESIS	FUT3 FUT4 FUT6	8.47e-06	5	135	3	M47966
Pathway	KEGG_MEDICUS_REFERENCE_SIALYL_LEWIS_X_ANTIGEN_BIOSYNTHESIS	FUT3 FUT4 FUT6	1.68e-05	6	135	3	M47967
Pathway	WP_GLYCOSAMINOGLYCAN_DEGRADATION	HEXA HEXB NAGLU IDUA	1.74e-05	17	135	4	M39832
Pathway	KEGG_GLYCOSAMINOGLYCAN_DEGRADATION	HEXA HEXB NAGLU IDUA	4.24e-05	21	135	4	M3624
Pathway	REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM	HEXA HEXB XYLT2 CHPF IDUA	9.20e-05	48	135	5	MM14696
Pathway	KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES	B3GNT5 FUT3 FUT4 FUT6	1.02e-04	26	135	4	M17377
Pathway	REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM	HEXA HEXB XYLT2 CHPF IDUA	1.12e-04	50	135	5	M678
Pathway	REACTOME_CS_DS_DEGRADATION	HEXA HEXB IDUA	2.29e-04	13	135	3	MM14805
Pathway	REACTOME_CS_DS_DEGRADATION	HEXA HEXB IDUA	2.89e-04	14	135	3	M651
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	DAB2IP HEXA SPEG NAGLU OBSCN DGKQ ATG2A MBD6 PHLDB1 PIK3C2B TMEM132A KBTBD11 MAP3K11 PLA2G6 CHPF PKN3 ANKRD13D LAMA5 KTI12 IDUA TEP1 HIVEP3 COQ4 DIP2C SOWAHB PCNT	6.08e-10	1105	193	26	35748872
Pubmed	Mouse AMACO, a kidney and skin basement membrane associated molecule that mediates RGD-dependent cell attachment.	LAMA1 COL7A1 FN1 LAMA5	6.32e-08	8	193	4	19651211
Pubmed	Heterologously overexpressed, affinity-purified human meprin alpha is functionally active and cleaves components of the basement membrane in vitro.	LAMA1 MEP1A LAMA5	1.68e-07	3	193	3	10620696
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	A1BG SPEG OBSCN DCC AMIGO3 NECTIN4 IGLON5 CNTN2 IGDCC3	3.37e-07	162	193	9	25826454
Pubmed	Distinct human α(1,3)-fucosyltransferases drive Lewis-X/sialyl Lewis-X assembly in human cells.	FUT3 FUT4 FUT6	1.67e-06	5	193	3	29593094
Pubmed	Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. A potential role in epidermal-dermal adherence in human skin.	LAMA1 COL7A1 FN1	1.67e-06	5	193	3	9169408
Pubmed	The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.	POGLUT3 NOX5 DHRS13 LRRC70 NUDT9 NXPE3 XYLT2 AMIGO3 CD163L1 SIGLEC10 TMEM231 CHPF PLXNA2 DNHD1 ROBO4 MRI1 LCN6 KIF7 MAN1B1	2.80e-06	985	193	19	12975309
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	DAB2IP RTEL1 PHLDB1 BAIAP3 RALGAPB TRIOBP DIP2C MACF1 PCNT	5.12e-06	225	193	9	12168954
Pubmed	alpha3beta1 Integrin is required for normal development of the epidermal basement membrane.	COL7A1 FN1 LAMA5	5.79e-06	7	193	3	9151677
Pubmed	DNA sequence and analysis of human chromosome 9.	DAB2IP NOL6 DMRT3 GSN-AS1 UHRF2 PKN3 NPR2 DYNC2I2 ADGRD2 MAN1B1 ERCC6L2-AS1	7.88e-06	370	193	11	15164053
Pubmed	Beta1 integrins are required for the invasion of the caecum and proximal hindgut by enteric neural crest cells.	LAMA1 FN1 LAMA5	9.23e-06	8	193	3	19633172
Pubmed	Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice.	LAMA1 FN1 LAMA5	1.38e-05	9	193	3	9882526
Pubmed	Basement membrane assembly of the integrin α8β1 ligand nephronectin requires Fraser syndrome-associated proteins.	LAMA1 COL7A1 FN1 LAMA5	1.96e-05	29	193	4	22613833
Pubmed	Twenty proteins containing a C-terminal SOCS box form five structural classes.	WSB1 CISH ASB2	1.96e-05	10	193	3	9419338
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	ZNF346 POGLUT3 CMTR1 NOL6 NAGLU ARL6IP6 CHPF NAT14 RALGAPB EDEM3 SCCPDH NEURL4 PCNT HDLBP WDTC1	2.28e-05	754	193	15	33060197
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	DAB2IP HEXB PHLDB1 PIK3C2B PLEKHA7 RALGAPB TRIOBP PLEKHA6 IARS2 MACF1 EPHA4	2.60e-05	421	193	11	36976175
Pubmed	Functional proteomics mapping of a human signaling pathway.	CISH MAST4 CHPF UHRF2 SDK1 MRI1 FN1 LAMA5 SKI MACF1 ASB2 ZMYM5 HDLBP	2.92e-05	591	193	13	15231748
Pubmed	Adapter protein SH2-Bbeta stimulates actin-based motility of Listeria monocytogenes in a vasodilator-stimulated phosphoprotein (VASP)-dependent fashion.	VASP SH2B1	3.06e-05	2	193	2	17452473
Pubmed	Laminin 5 binds the NC-1 domain of type VII collagen.	COL7A1 LAMA5	3.06e-05	2	193	2	9245798
Pubmed	Activity of lysosomal exoglycosidases in human gliomas.	HEXA HEXB	3.06e-05	2	193	2	16710745
Pubmed	Isolation of cDNA clones coding for the alpha-subunit of human beta-hexosaminidase. Extensive homology between the alpha- and beta-subunits and studies on Tay-Sachs disease.	HEXA HEXB	3.06e-05	2	193	2	3013851
Pubmed	Type VII collagen specifically binds fibronectin via a unique subdomain within the collagenous triple helix.	COL7A1 FN1	3.06e-05	2	193	2	7963647
Pubmed	Liberation of N-acetylglucosamine-6-sulfate by human beta-N-acetylhexosaminidase A.	HEXA HEXB	3.06e-05	2	193	2	6458607
Pubmed	Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases.	HEXA HEXB	3.06e-05	2	193	2	8789434
Pubmed	The laminin response in inflammatory bowel disease: protection or malignancy?	LAMA1 LAMA5	3.06e-05	2	193	2	25347196
Pubmed	Proteolytic processing of pro-alpha and pro-beta precursors from human beta-hexosaminidase. Generation of the mature alpha and beta a beta b subunits.	HEXA HEXB	3.06e-05	2	193	2	2965147
Pubmed	The biochemistry of HEXA and HEXB gene mutations causing GM2 gangliosidosis.	HEXA HEXB	3.06e-05	2	193	2	1825792
Pubmed	Plasma and peripheral leukocyte beta-N-acetylhexosaminidase isoenzymes and disease activity in rheumatoid arthritis.	HEXA HEXB	3.06e-05	2	193	2	12413610
Pubmed	A Pro504 --> Ser substitution in the beta-subunit of beta-hexosaminidase A inhibits alpha-subunit hydrolysis of GM2 ganglioside, resulting in chronic Sandhoff disease.	HEXA HEXB	3.06e-05	2	193	2	9694901
Pubmed	GM2 gangliosidoses in Spain: analysis of the HEXA and HEXB genes in 34 Tay-Sachs and 14 Sandhoff patients.	HEXA HEXB	3.06e-05	2	193	2	22789865
Pubmed	[Correlation between ultrastructural changes of glomerular basement membrane and abnormal distribution of laminins in patients with Alport's syndrome].	LAMA1 LAMA5	3.06e-05	2	193	2	20019771
Pubmed	Biochemical consequences of mutations causing the GM2 gangliosidoses.	HEXA HEXB	3.06e-05	2	193	2	10571007
Pubmed	Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism.	HEXA HEXB	3.06e-05	2	193	2	7550345
Pubmed	Neural precursor cell cultures from GM2 gangliosidosis animal models recapitulate the biochemical and molecular hallmarks of the brain pathology.	HEXA HEXB	3.06e-05	2	193	2	19166507
Pubmed	Dual-vector gene therapy restores cochlear amplification and auditory sensitivity in a mouse model of DFNB16 hearing loss.	STRC STRCP1	3.06e-05	2	193	2	34910522
Pubmed	Investigating Immune Responses to the scAAV9-HEXM Gene Therapy Treatment in Tay-Sachs Disease and Sandhoff Disease Mouse Models.	HEXA HEXB	3.06e-05	2	193	2	34201771
Pubmed	Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear.	CHRNA2 CHRNB4	3.06e-05	2	193	2	16826524
Pubmed	Novel bicistronic lentiviral vectors correct β-Hexosaminidase deficiency in neural and hematopoietic stem cells and progeny: implications for in vivo and ex vivo gene therapy of GM2 gangliosidosis.	HEXA HEXB	3.06e-05	2	193	2	31682993
Pubmed	Three novel mutations in Iranian patients with Tay-Sachs disease.	HEXA HEXB	3.06e-05	2	193	2	24518553
Pubmed	Down-regulation of β-N-acetyl-D-glucosaminidase increases Akt1 activity in thyroid anaplastic cancer cells.	HEXA HEXB	3.06e-05	2	193	2	21637923
Pubmed	Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.	HEXA HEXB	3.06e-05	2	193	2	9302266
Pubmed	Knock-down of HEXA and HEXB genes correlate with the absence of the immunostimulatory function of HSC-derived dendritic cells.	HEXA HEXB	3.06e-05	2	193	2	21997228
Pubmed	Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis.	HEXA HEXB	3.06e-05	2	193	2	8896570
Pubmed	Two mutations produce intron insertion in mRNA and elongated beta-subunit of human beta-hexosaminidase.	HEXB IDUA	3.06e-05	2	193	2	2170400
Pubmed	Association of alpha- and beta-subunits during the biosynthesis of beta-hexosaminidase in cultured human fibroblasts.	HEXA HEXB	3.06e-05	2	193	2	6230359
Pubmed	Classification of disorders of GM2 ganglioside hydrolysis using 3H-GM2 as substrate.	HEXA HEXB	3.06e-05	2	193	2	8123671
Pubmed	Genetic expression of hexokinase and glucose phosphate isomerase in late-stage mouse preimplantation embryos: transcription activities in glucose/phosphate-containing HTF and glucose/phosphate-free P1 media.	HEXA HEXB	3.06e-05	2	193	2	9237263
Pubmed	Presynaptic congenital myasthenic syndrome with a homozygous sequence variant in LAMA5 combines myopia, facial tics, and failure of neuromuscular transmission.	LAMA1 LAMA5	3.06e-05	2	193	2	28544784
Pubmed	Different expression of beta-N-acetylhexosaminidase in mouse tissues.	HEXA HEXB	3.06e-05	2	193	2	8147878
Pubmed	Orthologous relationship of obscurin and Unc-89: phylogeny of a novel family of tandem myosin light chain kinases.	SPEG OBSCN	3.06e-05	2	193	2	15185077
Pubmed	Identification of domains in human beta-hexosaminidase that determine substrate specificity.	HEXA HEXB	3.06e-05	2	193	2	8663217
Pubmed	Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB.	NAGLU IDUA	3.06e-05	2	193	2	12576554
Pubmed	Mutations in a new gene encoding a protein of the hair bundle cause non-syndromic deafness at the DFNB16 locus.	STRC STRCP1	3.06e-05	2	193	2	11687802
Pubmed	Correlation of FUT3 and FUT6 Gene Polymorphisms With Helicobacter pylori Infection.	FUT3 FUT6	3.06e-05	2	193	2	39108208
Pubmed	Pediatric reference data on activity of urinary N-acetyl-β-D-hexosaminidase and its isoenzymes.	HEXA HEXB	3.06e-05	2	193	2	28846871
Pubmed	Proteinases of the bone morphogenetic protein-1 family convert procollagen VII to mature anchoring fibril collagen.	BMP1 COL7A1	3.06e-05	2	193	2	11986329
Pubmed	I. Abnormalities in cells of the testis, efferent ducts, and epididymis in juvenile and adult mice with beta-hexosaminidase A and B deficiency.	HEXA HEXB	3.06e-05	2	193	2	10591618
Pubmed	The biosynthesis of the selectin-ligand sialyl Lewis x in colorectal cancer tissues is regulated by fucosyltransferase VI and can be inhibited by an RNA interference-based approach.	FUT4 FUT6	3.06e-05	2	193	2	20965272
Pubmed	Mycobacterium tuberculosis malate synthase is a laminin-binding adhesin.	LAMA1 FN1	3.06e-05	2	193	2	16677310
Pubmed	The positive feedback between Snail and DAB2IP regulates EMT, invasion and metastasis in colorectal cancer.	DAB2IP SNAI1	3.06e-05	2	193	2	26336990
Pubmed	Specificity of mouse GM2 activator protein and beta-N-acetylhexosaminidases A and B. Similarities and differences with their human counterparts in the catabolism of GM2.	HEXA HEXB	3.06e-05	2	193	2	9417048
Pubmed	Physiological substrates for human lysosomal beta -hexosaminidase S.	HEXA HEXB	3.06e-05	2	193	2	11707436
Pubmed	Promoters for the human beta-hexosaminidase genes, HEXA and HEXB.	HEXA HEXB	3.06e-05	2	193	2	8634145
Pubmed	Direct determination of the substrate specificity of the alpha-active site in heterodimeric beta-hexosaminidase A.	HEXA HEXB	3.06e-05	2	193	2	8672428
Pubmed	[Molecular pathogenesis and therapeutic approach of GM2 gangliosidosis].	HEXA HEXB	3.06e-05	2	193	2	23370522
Pubmed	Bacterial chitobiase structure provides insight into catalytic mechanism and the basis of Tay-Sachs disease.	HEXA HEXB	3.06e-05	2	193	2	8673609
Pubmed	Fibronectin binds and enhances the activity of bone morphogenetic protein 1.	BMP1 FN1	3.06e-05	2	193	2	19617627
Pubmed	Bicistronic lentiviral vector corrects beta-hexosaminidase deficiency in transduced and cross-corrected human Sandhoff fibroblasts.	HEXA HEXB	3.06e-05	2	193	2	15953731
Pubmed	Oligosaccharide structure and amino acid sequence of the major glycopeptides of mature human beta-hexosaminidase.	HEXA HEXB	3.06e-05	2	193	2	2971395
Pubmed	Mice deficient in all forms of lysosomal beta-hexosaminidase show mucopolysaccharidosis-like pathology.	HEXA HEXB	3.06e-05	2	193	2	9184660
Pubmed	Type VII collagen is required for Ras-driven human epidermal tumorigenesis.	COL7A1 LAMA5	3.06e-05	2	193	2	15774758
Pubmed	Crystallographic structure of human beta-hexosaminidase A: interpretation of Tay-Sachs mutations and loss of GM2 ganglioside hydrolysis.	HEXA HEXB	3.06e-05	2	193	2	16698036
Pubmed	Accumulated α-synuclein affects the progression of GM2 gangliosidoses.	HEXA HEXB	3.06e-05	2	193	2	27453479
Pubmed	Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression.	LAMA1 FN1	3.06e-05	2	193	2	25885552
Pubmed	Structure and expression of the mouse beta-hexosaminidase genes, Hexa and Hexb.	HEXA HEXB	3.06e-05	2	193	2	7959736
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	ATG2A TMEM132C ZNF469 PLEKHA7 VASP MAGED1 SH2B1 AP5B1 NEURL4 ZMYM5 PCNT	3.15e-05	430	193	11	35044719
Pubmed	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	A1BG HEXA HEXB ACAT2 NAGLU GAS6 OSCAR TMEM132A NECTIN4 DNM1 GOT1 ROBO4 FN1 LAMA5 IDUA PABPC3 LTBP2 CDH15	3.21e-05	1070	193	18	23533145
Pubmed	Multiple influences on the migration of precerebellar neurons in the caudal medulla.	DCC CNTN2 EPHA4	3.57e-05	12	193	3	11807023
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	LAMA1 BMP1 PLXNA2 COL7A1 FN1 LAMA5 LTBP2	5.85e-05	175	193	7	28071719
Pubmed	Composition of Drosophila melanogaster proteome involved in fucosylated glycan metabolism.	FUT3 FUT4 FUT6	7.29e-05	15	193	3	11698403
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	DAB2IP PHLDB1 CACTIN-AS1 KIF17 GOT1 NECAB2 MAGED1 FN1 TRIOBP LAMA5 SIPA1 KIF7	7.62e-05	560	193	12	21653829
Pubmed	An Interaction Landscape of Ubiquitin Signaling.	LAMA1 PIK3C2B DLAT ANKRD13D LAMA5 SCCPDH ZFYVE19 MACF1 NEURL4 PCNT HDLBP	8.60e-05	481	193	11	28190767
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	RTEL1 GAS6 OBSCN PHLDB1 PKD2 PLA2G6 ARHGAP8 BAIAP3 FAM53A RALGAPB TRIOBP SKI TEP1 SH2B1 HIVEP3 DIP2C MACF1 SLC2A11 CDH15 MAN1B1 PCNT	8.92e-05	1489	193	21	28611215
Pubmed	Glycosphingolipid degradation and animal models of GM2-gangliosidoses.	HEXA HEXB	9.16e-05	3	193	2	9728335
Pubmed	Cochlear outer hair cell horizontal top connectors mediate mature stereocilia bundle mechanics.	STRC STRCP1	9.16e-05	3	193	2	30801007
Pubmed	Association between RTEL1, PHLDB1, and TREH Polymorphisms and Glioblastoma Risk: A Case-Control Study.	RTEL1 PHLDB1	9.16e-05	3	193	2	26156397
Pubmed	FUT family mediates the multidrug resistance of human hepatocellular carcinoma via the PI3K/Akt signaling pathway.	FUT4 FUT6	9.16e-05	3	193	2	24232099
Pubmed	Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB.	NAGLU IDUA	9.16e-05	3	193	2	22558223
Pubmed	The extracellular matrix is a novel attribute of endothelial progenitors and of hypoxic mature endothelial cells.	LAMA1 FN1	9.16e-05	3	193	2	22919069
Pubmed	Tay-Sachs' and Sandhoff's diseases: the assignment of genes for hexosaminidase A and B to individual human chromosomes.	HEXA HEXB	9.16e-05	3	193	2	1054503
Pubmed	Characterization of the testis and epididymis in mouse models of human Tay Sachs and Sandhoff diseases and partial determination of accumulated gangliosides.	HEXA HEXB	9.16e-05	3	193	2	9645704
Pubmed	Hyaluronidase 1 and β-hexosaminidase have redundant functions in hyaluronan and chondroitin sulfate degradation.	HEXA HEXB	9.16e-05	3	193	2	22451654
Pubmed	Development of immunohistochemistry assays to assess GALNT14 and FUT3/6 in clinical trials of dulanermin and drozitumab.	FUT3 FUT6	9.16e-05	3	193	2	20179215
Pubmed	Fibulin-2 binds to the short arms of laminin-5 and laminin-1 via conserved amino acid sequences.	LAMA1 LAMA5	9.16e-05	3	193	2	9006922
Pubmed	Laminin isoform-specific promotion of adhesion and migration of human bone marrow progenitor cells.	LAMA1 LAMA5	9.16e-05	3	193	2	12393739
Pubmed	α1- and α5-containing laminins regulate the development of bile ducts via β1 integrin signals.	LAMA1 LAMA5	9.16e-05	3	193	2	22761447
Pubmed	Mouse model of GM2 activator deficiency manifests cerebellar pathology and motor impairment.	HEXA HEXB	9.16e-05	3	193	2	9223328
Pubmed	TFCP2c/LSF/LBP-1c is required for Snail1-induced fibronectin gene expression.	FN1 SNAI1	9.16e-05	3	193	2	21361876
Pubmed	Expression of human chromosome 19p alpha(1,3)-fucosyltransferase genes in normal tissues. Alternative splicing, polyadenylation, and isoforms.	FUT3 FUT6	9.16e-05	3	193	2	7650030
Pubmed	Association of sequence variants on chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15.33) with glioma susceptibility in a Chinese population.	RTEL1 PHLDB1	9.16e-05	3	193	2	21350045
Interaction	LLCFC1 interactions	POGLUT3 NAGLU GAS6 BMP1 TMEM132A CHPF PLXNA2 LAMA5 IDUA EDEM3 DCHS1	1.45e-08	121	184	11	int:LLCFC1
Interaction	SCGB2A2 interactions	POGLUT3 LAMA1 NAGLU NXPE3 XYLT2 BMP1 TMEM132A ADAMTS17 CHPF VASP FN1 LAMA5 IDUA SCCPDH	1.84e-08	223	184	14	int:SCGB2A2
Interaction	COL7A1 interactions	LAMA1 BMP1 COL7A1 FN1 LAMA5	2.75e-06	25	184	5	int:COL7A1
Interaction	CA6 interactions	RTEL1 GAS6 BMP1 PLXNA2 LAMA5 IDUA EDEM3	3.16e-06	69	184	7	int:CA6
Interaction	GPIHBP1 interactions	NXPE3 XYLT2 BMP1 ADAMTS17 CHPF PLXNA2 LAMA5 IDUA EDEM3	3.73e-06	133	184	9	int:GPIHBP1
Interaction	CBLN4 interactions	POGLUT3 NAGLU BMP1 TMEM132A LAMA5 IDUA EDEM3 SNAI1	2.20e-05	127	184	8	int:CBLN4
Interaction	C1orf54 interactions	LAMA1 GAS6 NXPE3 AMIGO3 TMEM132A ADAMTS17 PLXNA2 LAMA5 IDUA	2.35e-05	167	184	9	int:C1orf54
Interaction	FBXO2 interactions	HEXB POGLUT3 LAMA1 NAGLU GAS6 BMP1 AMIGO3 PKD2 TMEM231 PLXNA2 FN1 LAMA5 NFS1 IDUA	2.63e-05	411	184	14	int:FBXO2
Interaction	MFAP4 interactions	POGLUT3 NAGLU BMP1 TMEM132A PLXNA2 LAMA5 IDUA EDEM3	4.22e-05	139	184	8	int:MFAP4
Interaction	MEP1A interactions	LAMA1 MEP1A FN1 LAMA5	6.19e-05	24	184	4	int:MEP1A
Interaction	TOP3B interactions	DAB2IP HEXA RTEL1 SPEG NAGLU OBSCN DGKQ ATG2A MBD6 PHLDB1 PIK3C2B TMEM132A KBTBD11 MAP3K11 DLAT PLA2G6 CHPF PKN3 ANKRD13D LAMA5 KTI12 IDUA TEP1 HIVEP3 COQ4 DIP2C SOWAHB PCNT HDLBP	6.77e-05	1470	184	29	int:TOP3B
Cytoband	9q34.11	PKN3 DYNC2I2 MIGA2 COQ4	7.55e-05	53	193	4	9q34.11
Cytoband	Ensembl 112 genes in cytogenetic band chr9q34	DNM1 PKN3 DYNC2I2 FPGS LCN6 MIGA2 COQ4 MAN1B1	7.69e-05	325	193	8	chr9q34
Cytoband	19p13.3	PEAK3 CACTIN-AS1 GRIN3B TLE6 FUT3 FUT6	5.28e-04	237	193	6	19p13.3
GeneFamily	Fibronectin type III domain containing	OBSCN DCC SDK1 CNTN2 ROBO4 COL7A1 FN1 IGDCC3 EPHA4	3.02e-06	160	134	9	555
GeneFamily	Immunoglobulin like domain containing	A1BG SLAMF8 OSCAR DCC AMIGO3 SDK1 IGLON5 CNTN2	9.65e-05	193	134	8	594
GeneFamily	Fucosyltransferases\|Blood group antigens	FUT3 FUT4 FUT6	1.08e-04	13	134	3	434
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	SPEG OBSCN DCC SDK1 CNTN2 ROBO4 IGDCC3	1.99e-04	161	134	7	593
GeneFamily	Bone morphogenetic proteins\|Astacins	MEP1A BMP1	8.02e-04	6	134	2	894
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PHLDB1 DNM1 PLEKHA7 TRIOBP PLEKHA6 SH2B1 GAB3	8.72e-04	206	134	7	682
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	ARHGAP8 BNIPL	1.12e-03	7	134	2	1299
GeneFamily	WD repeat domain containing	WSB1 DYNC2I2 EML4 FBXW4 TEP1 TLE6 WDTC1	3.42e-03	262	134	7	362
GeneFamily	Laminin subunits	LAMA1 LAMA5	3.43e-03	12	134	2	626
ToppCell	severe_COVID-19-pDC\|severe_COVID-19 / disease group, cell group and cell class (v2)	GAS6 FBXO24 AJAP1 TMEM231 KIF17 NPR2 MAGED1 BNIPL	4.83e-07	159	193	8	ea5088d27e42b8850455764d53b757ea8d8f14bc
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA1 OBSCN DCC SDK1 CNTN2 GALNTL6 OTOA ANO3	1.45e-06	184	193	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA1 OBSCN DCC SDK1 CNTN2 GALNTL6 OTOA ANO3	1.45e-06	184	193	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA1 OBSCN DCC SDK1 CNTN2 GALNTL6 OTOA ANO3	1.45e-06	184	193	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SPEG ADARB2 PHLDB1 PLXNA2 NAT14 ATRNL1 SLCO2A1 LTBP2	1.64e-06	187	193	8	387cb27c8a20031cd87381a9e1172f1f62e1488b
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	SPEG PHLDB1 PLXNA2 NAT14 ATRNL1 SLCO2A1 GAB3 LTBP2	1.78e-06	189	193	8	0abc7a4900cc9033bc1be69b770ccc54a6bf41b4
ToppCell	severe_COVID-19-pDC\|World / disease group, cell group and cell class (v2)	GAS6 FBXO24 AJAP1 TMEM231 KIF17 NPR2 BNIPL	6.17e-06	159	193	7	e1c48c4ceda116826819ff9adeed7bad6a58844d
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ADARB2 ADAMTS17 FOXP3 RTL1 BNIPL LTBP2	6.17e-06	104	193	6	b5ca6e589f414e549f4990fe334d4ee54829b298
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-NK/T\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF831 STAR CD163L1 KBTBD11 BAIAP3 FOXP3 APBB1	6.69e-06	161	193	7	140b3c7077947c541cff54f6754e2df968345f4d
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-NK_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF831 STAR CD163L1 KBTBD11 BAIAP3 FOXP3 APBB1	6.97e-06	162	193	7	16f9fbcaa0093ffc5a2a5e32db6040e2cb519d47
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DHRS13 ADARB2 CHRNA2 SDK1 GALNTL6 NECAB2 SHISA8	7.26e-06	163	193	7	39181c58387189a815e7b3eb29fbd1dd4ee24d0a
ToppCell	droplet-Liver-Hepatocytes-21m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A1BG UGT3A1 ALDH8A1 BMP1 SLC27A5 FN1 FPGS	7.55e-06	164	193	7	90afae3cca108ebfb44ff2ec4adcbb8c68a0bdf2
ToppCell	facs-Marrow-Granulocytes-24m-Hematologic-hematopoietic_stem_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HEXB OSCAR DNM1 ARHGAP8 LAMA5 PERM1 COQ4	9.55e-06	170	193	7	8d3c51364a332020810836e2055c60893c10d7f3
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122\|Adult / Lineage, Cell type, age group and donor	OBSCN PHLDB1 AJAP1 PLXNA2 PKN3 ROBO4 SLCO2A1	9.92e-06	171	193	7	bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc
ToppCell	Control-Myeloid-MoAM2,_CCL18\|Control / Condition, Lineage and Cell class	NOX5 CD163L1 UCN DNM1 OTOA FN1 LTBP2	1.11e-05	174	193	7	4c64ff5666812fb4efa440ba4faeca51d916d68e
ToppCell	LPS-IL1RA-Endothelial-Epi-like\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TGFBR3L PEAK3 FBXO24 NECAB2 FBXW4 C1orf74	1.16e-05	116	193	6	cf4e3c34570f57502ec524881d351ef8e47976d2
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ADARB2 CHRNA2 SDK1 GALNTL6 IGDCC3 KLHDC8A SHISA8	1.24e-05	177	193	7	85e270b4a0b0da77ffe5987a099e827c02a4adf3
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCC ADARB2 CHRNA2 CD163L1 SDK1 GALNTL6 SHISA8	1.24e-05	177	193	7	84116796ca4c7007508c0f1a68a1135c7b922278
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NXPE3 PHLDB1 MAST4 PKN3 ANKRD13D ROBO4 RALGAPB	1.34e-05	179	193	7	025d414ec88d5680d99c8173e70ee3bb0b694f74
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ADARB2 CHRNA2 SDK1 GALNTL6 IGDCC3 KLHDC8A SHISA8	1.49e-05	182	193	7	3d7a8d2ee2137b098248597058974ef5ae09c19e
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ADARB2 CHRNA2 CD163L1 ADAMTS17 SDK1 GALNTL6 SHISA8	1.49e-05	182	193	7	d3a037268f026eb2f84428b1821022503cef7756
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ADARB2 CHRNA2 CD163L1 ADAMTS17 SDK1 GALNTL6 SHISA8	1.65e-05	185	193	7	0b5a0df58ae2ad8261f40f152775747af4f3937a
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DCC CHRNB4 TMEM132C SDK1 OTOA PLEKHA6	1.77e-05	125	193	6	b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	DCC ADAMTS17 SDK1 FN1 MACF1 LTBP2 ANO3	1.77e-05	187	193	7	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SPEG GAS6 NAT14 ATRNL1 DCHS1 LTBP2 ASB2	1.83e-05	188	193	7	c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-large_intestine_goblet_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHRNB4 ADAMTS17 MON1A EDEM3 KLHDC8A FUT4 HDLBP	2.17e-05	193	193	7	6a9bce5064938b5b84ad57b4fd4a7841afe100c8
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	HEXB OSCAR VASP FN1 EML4 SCCPDH ABHD5	2.32e-05	195	193	7	f664fe18856065baaa2837fc82ea946e45f6fcc3
ToppCell	356C-Myeloid-Macrophage-SPP1+_Macrophage_3\|356C / Donor, Lineage, Cell class and subclass (all cells)	SLAMF8 HEXA HEXB B3GNT5 OSCAR OTOA OAS1	2.40e-05	196	193	7	48f7516129570981846c667a07abe5a9abe62dcd
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	POGLUT3 TMEM132C ADAMTS17 MAGED1 FN1 HIVEP3 MACF1	2.40e-05	196	193	7	2a885eed52f9b002c7995e11e450c7e8d7ae69e6
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	POGLUT3 TMEM132C ADAMTS17 MAGED1 FN1 HIVEP3 MACF1	2.40e-05	196	193	7	14246f00c90741a5f8683f377e22e3a7c99661b9
ToppCell	5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GAS6 MAST4 PKN3 FN1 LCN6 SLCO2A1 EPHA4	2.47e-05	197	193	7	61b1b10a017cbeb17f8529fcae66cba77ee2f115
ToppCell	5'-Adult-Appendix-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GAS6 MAST4 PKN3 ROBO4 LAMA5 LCN6 SLCO2A1	2.47e-05	197	193	7	e8e879b7634a29569061d3515d180784094a31e7
ToppCell	5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_arterial_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GAS6 MAST4 PKN3 FN1 LCN6 SLCO2A1 EPHA4	2.56e-05	198	193	7	8a55589b9244283e4b0b423a4a6d6202e8e0fec9
ToppCell	5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GAS6 MAST4 PLXNA2 PKN3 FN1 SLCO2A1 EPHA4	2.56e-05	198	193	7	58508a8df2714d769f137794c29441a7bd38b350
ToppCell	TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma\|TCGA-Bladder / Sample_Type by Project: Shred V9	SLAMF8 SRD5A1 OSCAR BMP1 FOXP3 FN1 MAN1B1	2.56e-05	198	193	7	65875fbd99393cdd62595c713ab90db06d28081f
ToppCell	BAL-Control-Myeloid-TRAM-TRAM2-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	B3GNT5 OSCAR CISH VASP EML4 ABHD5 HDLBP	2.64e-05	199	193	7	b8dc5dc9fe3f52be11940d45959134b2a7575a8b
ToppCell	BAL-Control-Myeloid-TRAM-TRAM2-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	B3GNT5 OSCAR CISH VASP EML4 ABHD5 HDLBP	2.64e-05	199	193	7	bbf81fb20da8a28aac024207696c6ea00473a0df
ToppCell	BAL-Control-Myeloid-TRAM-TRAM2\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	B3GNT5 OSCAR CISH VASP EML4 ABHD5 HDLBP	2.64e-05	199	193	7	90b20fce27739f28609d664475a197eea586e030
ToppCell	Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MAST4 PIK3C2B PKN3 FN1 LCN6 SLCO2A1 EPHA4	2.64e-05	199	193	7	6a2943a23fdd2ec814662db7c21a0d6804a6cbbc
ToppCell	BAL-Control-Myeloid-TRAM-TRAM2\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	B3GNT5 OSCAR CISH VASP EML4 ABHD5 HDLBP	2.64e-05	199	193	7	617fd53c799722879acd8f2fd69b331d82e7bdb9
ToppCell	Control-Myeloid-TRAM2\|Control / Disease group,lineage and cell class （2021.01.30）	B3GNT5 OSCAR CISH VASP EML4 ABHD5 HDLBP	2.64e-05	199	193	7	5a08184573e524ce0e2974eed9817354890830a9
ToppCell	Neuronal-Excitatory-eC(RORB)-eC_1-TWIST2-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	DCC CD163L1 USP43 SLCO2A1 ASB2 ANO3 EPHA4	2.73e-05	200	193	7	af5d4a3d735f38c6e07b5d7bd2965b0486632c4e
ToppCell	Neuronal-Excitatory-eC(RORB)-eC_1-TWIST2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	DCC CD163L1 USP43 SLCO2A1 ASB2 ANO3 EPHA4	2.73e-05	200	193	7	bbfbefd24cc070b010e787e08ff6bff4a7ee3f7c
ToppCell	Neuronal-Excitatory-eC(RORB)-eC_1-TWIST2--L3-5\|Neuronal / cells hierarchy compared to all cells using T-Statistic	DCC CD163L1 USP43 SLCO2A1 ASB2 ANO3 EPHA4	2.73e-05	200	193	7	b9ef0e11c8e22f2c9c926fd48fa2005ef8d22752
ToppCell	BAL-Mild-Myeloid-TRAM-TRAM2-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	B3GNT5 OSCAR PKN3 NPR2 PLEKHA6 BNIPL	5.12e-05	151	193	6	28e3f77d2edb30fcf1414762a55ceffaf879d526
ToppCell	BAL-Mild-Myeloid-TRAM-TRAM2\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	B3GNT5 OSCAR PKN3 NPR2 PLEKHA6 BNIPL	5.12e-05	151	193	6	688cc5e4d46ba16f9b431352d7a6d39b21941e9c
ToppCell	BAL-Mild-Myeloid-TRAM-TRAM2-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	B3GNT5 OSCAR PKN3 NPR2 PLEKHA6 BNIPL	5.12e-05	151	193	6	45392bb1c6358beff33da0ca84f7696fb5824f30
ToppCell	BAL-Mild-Myeloid-TRAM-TRAM2\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	B3GNT5 OSCAR PKN3 NPR2 PLEKHA6 BNIPL	5.12e-05	151	193	6	3d861285c71abe220b19a069eb9876199c6c8f39
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SPEG KIF7 LTBP2 SNAI1 ASB2 ANO3	5.51e-05	153	193	6	1524557514668f515ac1bbe847611f564b265b42
ToppCell	Mild_COVID-19-Myeloid-TRAM2\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	B3GNT5 OSCAR PKN3 NPR2 PLEKHA6 BNIPL	5.72e-05	154	193	6	ab648f6b29eb9e499e46cbdbaf3c5cf6b94d1f64
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CSMD2 TMEM132C CACTIN-AS1 GALNTL6 ATRNL1 RIMBP2	5.93e-05	155	193	6	77fdae85d36efb776db977eb424b32487ef222e4
ToppCell	356C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	KIF17 BAIAP3 ATRNL1 KLHDC8A DIP2C EPHA4	6.36e-05	157	193	6	f6210be2362d833c6d869ff921188bfc85dda11d
ToppCell	356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	KIF17 BAIAP3 ATRNL1 KLHDC8A DIP2C EPHA4	6.36e-05	157	193	6	43a6b423fd70479822a564ff4225a1e4951ae5ed
ToppCell	severe_COVID-19-cDC\|severe_COVID-19 / disease group, cell group and cell class (v2)	SLAMF8 GAS6 ZNF469 IGLON5 KIF7 ASB2	6.36e-05	157	193	6	ec1978e07e2214048d015d8bb793c1d9991f6e37
ToppCell	droplet-Kidney-nan-3m-Myeloid-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 HEXB NECTIN4 SLC27A5 IDUA TLE6	6.83e-05	159	193	6	bea6e96ba40ebfc1e38687bfa1c61fe227c5a84d
ToppCell	severe_influenza-cDC\|severe_influenza / disease group, cell group and cell class (v2)	FAM178B NECTIN4 STRC TMEM231 GALNTL6 ASB2	7.31e-05	161	193	6	7716315b8bda904b346cea47edc2c0b507a345c2
ToppCell	368C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	A1BG ALDH8A1 KIF17 LCN6 LTBP2 ANO3	8.10e-05	164	193	6	dd29decc6c41a580cfdf03962827ec18d432935f
ToppCell	368C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	A1BG ALDH8A1 KIF17 LCN6 LTBP2 ANO3	8.10e-05	164	193	6	dcd3c3ee73900180451fad9b4de0efedbd375e1c
ToppCell	10x5'-bone_marrow-Lymphocytic_B_plasma-Plasmablasts\|bone_marrow / Manually curated celltypes from each tissue	GAS6 AMIGO3 CHPF DYNC2I2 PTPN21 HDLBP	8.10e-05	164	193	6	67260e9f569f0acaeb0e65f69cde230f91cd3d26
ToppCell	Children_(3_yrs)-Mesenchymal-chondrocyte-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NOL6 PLEKHA6 KIF7 ARHGEF39 LTBP2 FUT6	8.95e-05	167	193	6	f4943fb5001475ddab82a0273bcbb3fa68fdd7bd
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CES5A CISH BMP1 BAIAP3 MAGED1 BNIPL	8.95e-05	167	193	6	b94e8ee8c3fcebedd8fcd719eadddc04c7513c50
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4\|TCGA-Lung / Sample_Type by Project: Shred V9	BMP1 ZNF469 SIGLEC10 FOXP3 MCHR1 SNAI1	9.25e-05	168	193	6	aefea14b8b1c1b6a05f827effd22ba15274fddc9
ToppCell	facs-Aorta-Heart-24m-Endothelial-endocardial_endothelial_cells\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADARB2 ARHGAP8 PLEKHA7 PKN3 SLCO2A1 DYNLT4	9.25e-05	168	193	6	edbab94f14e16a1a76546a18fe777a183080d1de
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-T_cells-Th17\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CISH XYLT2 ZNF469 EML4 SLC30A6 GAB3	9.25e-05	168	193	6	97bf074b91c9ae0064edc31fa4a2658ffdcfefa3
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CMAHP\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCC CD163L1 USP43 KLHDC8A ASB2 ANO3	9.25e-05	168	193	6	1d58731a481ecac84c15affa84f8041dd67d944c
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCC BAIAP3 USP43 ASB2 ANO3 EPHA4	9.87e-05	170	193	6	3174ea9cf93892a8b41de10fd4ff6f06bb41502d
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ADARB2 CHRNA2 CD163L1 ADAMTS17 SDK1 SHISA8	9.87e-05	170	193	6	36dbbdb13f69307afd2122ff051b2980850c1f00
ToppCell	mild_COVID-19_(asymptomatic)-cDC\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	SLAMF8 GAS6 KIF17 KIF7 ADGRD2 ASB2	1.09e-04	173	193	6	71dc0051c87b84e3cf13cde8858166f2a474b5dc
ToppCell	TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-10\|TCGA-Bladder / Sample_Type by Project: Shred V9	SLAMF8 OSCAR BMP1 SIGLEC10 FOXP3 LTBP2	1.12e-04	174	193	6	96f1d025af3a5bf616926a558885d196c3cd2709
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ADARB2 CD163L1 CACTIN-AS1 SDK1 GALNTL6 SHISA8	1.16e-04	175	193	6	5a9160a9d05e01d945e77fd81bb0bd87139545cd
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CMAHP\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCC CD163L1 USP43 KLHDC8A ASB2 ANO3	1.16e-04	175	193	6	d4827b4dfad07f11cbdd47fbed287af1afb9b1b8
ToppCell	droplet-Marrow-BM-1m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHPF CCDC157 MEF2B SCCPDH DIP2C MAN1B1	1.19e-04	176	193	6	2e9073166da4d9fae70ba4f3fdcad35523caf7cd
ToppCell	Caecum-Dendritic_cell-cDC1\|Dendritic_cell / Region, Cell class and subclass	DLAT SLC27A5 RALGAPB NFS1 ZNF446 ASB2	1.19e-04	176	193	6	07cde50e1c18fcc2c5028efe1a087db4ef4d4783
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TGFBR3L ADAMTS17 FN1 HIVEP3 MACF1 SNAI1	1.19e-04	176	193	6	cb8fd56a4f935cdda19d7ab43382cdda7c307667
ToppCell	PBMC-Mild-cDC_11\|Mild / Compartment, Disease Groups and Clusters	SLAMF8 SIGLEC10 STRC SDK1 LAMA5 ASB2	1.23e-04	177	193	6	974305e4c0eff90134c4e58cf11b955d1eee0501
ToppCell	Control-Myeloid-MoAM2,_CCL18\|Myeloid / Condition, Lineage and Cell class	NOX5 CD163L1 DNM1 OTOA FN1 LTBP2	1.23e-04	177	193	6	470f54fe2b21c7350ea471e02039461a3808f700
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KIF17 PKN3 ROBO4 LCN6 SLCO2A1 EPHA4	1.23e-04	177	193	6	fdf2af00fc971f0cd3915e1416e4a256458d6ea8
ToppCell	facs-Marrow-Granulocytes-24m-Hematologic-MPP_Fraction_B\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HEXB OSCAR DNM1 LAMA5 PERM1 COQ4	1.23e-04	177	193	6	4a697866ed542d3201714234cee03451adf1dcc9
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.6.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SLAMF8 HEXA HEXB OSCAR CHRNB4 OTOA	1.23e-04	177	193	6	929cd8f530ce001623735da53b7278d02522e2b5
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KIF17 PKN3 ROBO4 LCN6 SLCO2A1 EPHA4	1.23e-04	177	193	6	12f8627124acbf436e75681ff1ce429ff5e3f256
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NOX5 GRIN3B TMEM231 BAIAP3 SDK1 RIMBP2	1.31e-04	179	193	6	5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff
ToppCell	367C-Lymphocytic-ILC-ILC-2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	POGLUT3 ATG2A TMEM231 FBXW4 SLC30A6 AP5B1	1.31e-04	179	193	6	5aa8465e943b6b666c7f8b1937fcc3764bfe91f6
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PIK3C2B ROBO4 FN1 SLCO2A1 DCHS1 EPHA4	1.31e-04	179	193	6	8f9e538c822940785130297712b75131812a4603
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GAS6 ADARB2 AJAP1 PKD2 SCCPDH PROSER2	1.31e-04	179	193	6	55bc69f107fc710db7617c428575792adfdbbcc1
ToppCell	E15.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ADAMTS17 MAGED1 FN1 HIVEP3 MACF1 SNAI1	1.31e-04	179	193	6	b559f5a72cc9e3e35d05cb539b5c2e006e56e652
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCC ADARB2 CHRNA2 SDK1 GALNTL6 NECAB2	1.31e-04	179	193	6	97ba67a856680f24846244c0b92c886cc0e79537
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DCC TMEM132C ADAMTS17 SDK1 PLEKHA6 HIVEP3	1.35e-04	180	193	6	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	IIH-CD8-CD4_Treg\|IIH / Condition, Cell_class and T cell subcluster	PLA2G6 HCFC2 FOXP3 FBXW4 C1orf74 NFS1	1.35e-04	180	193	6	d1a8b25115c80e5a5bd0b8244167a98250ab9778
ToppCell	MatrixFB-Fibroblast-A\|MatrixFB / shred on cell class and cell subclass (v4)	POGLUT3 ADAMTS17 FN1 EML4 HIVEP3 MACF1	1.35e-04	180	193	6	adc64ad6033af705dd7b9163a83e20ef5c59f6eb
ToppCell	severe-CD8+_T_naive\|severe / disease stage, cell group and cell class	ARHGAP8 GOT1 DNHD1 FAHD2B POT1 NCOA1	1.35e-04	180	193	6	94fe530367b170777f4051a4034cff06d80dbb83
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ADARB2 CHRNA2 CD163L1 SDK1 GALNTL6 SHISA8	1.39e-04	181	193	6	062f00736eed96e4f4327615d093558dd7d82b20
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ADARB2 CHRNA2 SDK1 GALNTL6 KLHDC8A SHISA8	1.39e-04	181	193	6	35bcdcd2651149692e5b150e887c0f450c81d2d4
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_DSEL\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ADARB2 CHRNA2 CACTIN-AS1 SDK1 GALNTL6 SHISA8	1.39e-04	181	193	6	70eff83dd85691e977972c660731394d2fcf5cdf
ToppCell	severe-CD8+_T_naive\|World / disease stage, cell group and cell class	ARHGAP8 GOT1 DNHD1 FAHD2B POT1 NCOA1	1.39e-04	181	193	6	69eeeb7f326e230b07495d557f708fbe3312ac0a
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PHLDB1 TMEM132A NAT14 FN1 ATRNL1 LTBP2	1.39e-04	181	193	6	d7e04e0ca549eac6d9b1192b6578f9b54943d54f
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM132A DNM1 SDK1 IGLON5 IGDCC3 TLE6	1.39e-04	181	193	6	7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ADARB2 CHRNA2 SDK1 GALNTL6 IGDCC3 SHISA8	1.39e-04	181	193	6	154d5e586cab25155c6d06dfe6ae01203b88e0fb
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ADARB2 CHRNA2 CD163L1 SDK1 GALNTL6 SHISA8	1.39e-04	181	193	6	7846c7b33d1b89364c5a704edaa86520db731c89
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ADARB2 CHRNA2 SDK1 GALNTL6 NECAB2 SHISA8	1.43e-04	182	193	6	420a8fd30543e37a66ba0786215d056d308660d0
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PHLDB1 COL7A1 FN1 ATRNL1 DIP2C LTBP2	1.43e-04	182	193	6	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
Drug	chitotriose	HEXA HEXB ACAT2 STAR FUT3 FUT6	2.29e-07	32	189	6	CID000444514
Drug	rabdosiin	HEXA HEXB NOX5	2.24e-06	4	189	3	CID000471121
Drug	NP-009007	HEXA HEXB NAGLU	2.24e-06	4	189	3	CID011390848
Drug	oxyphyllol A	HEXA HEXB NAGLU	2.24e-06	4	189	3	CID000637451
Drug	2'-fucosyllactose	HEXA CHPF FUT3 FUT4 FUT6	4.50e-06	30	189	5	CID000170484
Drug	Glycocholic acid [475-31-0]; Up 200; 8.6uM; MCF7; HT_HG-U133A	RTEL1 BMP1 PHLDB1 UCN TMEM231 BAIAP3 VASP NPR2 PLEKHA6 SIPA1	5.89e-06	196	189	10	3315_UP
Drug	(S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; MCF7; HT_HG-U133A	RTEL1 GAS6 XYLT2 PLXNA2 COL7A1 PLEKHA6 PTPN21 SLCO2A1 FUT4 WDTC1	6.16e-06	197	189	10	3870_DN
Drug	Isoniazid [54-85-3]; Up 200; 29.2uM; PC3; HT_HG-U133A	RTEL1 ATG2A CISH PHLDB1 COL7A1 TRMO ZNF446 EDEM3 ZMYM5 EPHA4	6.44e-06	198	189	10	2083_UP
Drug	Suxibuzone [27470-51-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A	RTEL1 BMP1 PHLDB1 TMEM231 FN1 TRIOBP SLCO2A1 DCHS1 FUT4 SLC2A11	6.74e-06	199	189	10	7163_UP
Drug	colchicine; Down 200; 0.1uM; MCF7; HG-U133A	WSB1 NOX5 SRD5A1 NAGLU BMP1 BAIAP3 NPR2 RALGAPB ZNF446 NCOA1	6.74e-06	199	189	10	644_DN
Drug	AC1MPID6	FUT3 FUT4 FUT6	1.11e-05	6	189	3	CID003411618
Drug	AC1MPID3	CHPF FUT3 FUT4 FUT6	1.62e-05	19	189	4	CID003411617
Drug	dN x	HEXA HEXB NAGLU	1.92e-05	7	189	3	CID000011348
Drug	lactosylceramide	HEXA HEXB B3GNT5 NOX5 HCFC2 CHPF FN1 FUT4	2.28e-05	140	189	8	CID006450208
Drug	Captopril [62571-86-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A	WSB1 DGKQ AJAP1 PLA2G6 FN1 OAS1 SIPA1 HIVEP3 LTBP2	3.53e-05	193	189	9	4410_DN
Drug	Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A	RTEL1 NXPE3 PHLDB1 PLA2G6 CHPF FN1 TEP1 FUT4 WDTC1	3.68e-05	194	189	9	5268_DN
Drug	Moxalactam disodium salt [64953-12-4]; Up 200; 7uM; MCF7; HT_HG-U133A	SLAMF8 WSB1 CHRNA2 PLA2G6 TRIOBP PLEKHA6 ZNF446 FUT6 SLC2A11	3.68e-05	194	189	9	5609_UP
Drug	Omeprazole [73590-58-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A	RTEL1 DGKQ COL7A1 TEP1 ZNF446 LTBP2 FUT6 SLC2A11 WDTC1	3.68e-05	194	189	9	4951_UP
Drug	Cefoperazone dihydrate; Down 200; 5.8uM; MCF7; HT_HG-U133A	WSB1 RTEL1 MAST4 PIK3C2B TMEM231 FN1 PLEKHA6 PTPN21 TEP1	3.83e-05	195	189	9	5424_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	XYLT2 PHLDB1 MAST4 SSH3 PLA2G6 TMEM231 PTPN21 FUT6 WDTC1	3.99e-05	196	189	9	5563_DN
Drug	nordihydroguaiaretic acid; Down 200; 1uM; PC3; HT_HG-U133A	SPEG KBTBD11 PLA2G6 FN1 IDUA ZNF446 FUT4 ZMYM5 WDTC1	4.31e-05	198	189	9	4447_DN
Drug	Ampyrone [83-07-8]; Up 200; 19.6uM; HL60; HG-U133A	NOX5 NAGLU CHRNA2 PLA2G6 CHPF FOXP3 ROBO4 SH2B1 DIP2C	4.31e-05	198	189	9	1402_UP
Drug	Folic acid [59-30-3]; Down 200; 9uM; PC3; HT_HG-U133A	CISH BMP1 FPGS TRMO PLEKHA6 HIVEP3 FUT4 FUT6 MAN1B1	4.49e-05	199	189	9	5844_DN
Drug	Gly-His-Lys acetate salt; Down 200; 1uM; PC3; HT_HG-U133A	WSB1 SSH3 TMEM132A TMEM231 PTPN21 HIVEP3 NCOA1 FUT4 WDTC1	4.49e-05	199	189	9	6560_DN
Drug	Tomatidine [77-59-8]; Up 200; 9.6uM; MCF7; HT_HG-U133A	BMP1 AJAP1 TMEM231 BAIAP3 FN1 TEP1 SLCO2A1 LTBP2 WDTC1	4.66e-05	200	189	9	7166_UP
Drug	Pivmecillinam hydrochloride [32887-03-9]; Up 200; 8.4uM; PC3; HT_HG-U133A	WSB1 CISH BAIAP3 FN1 TRMO SH2B1 LTBP2 FUT3 FUT6	4.66e-05	200	189	9	7312_UP
Drug	Oxytetracycline dihydrate [6153-64-6]; Down 200; 8uM; PC3; HT_HG-U133A	GAS6 PHLDB1 COL7A1 NPR2 FN1 TRIOBP TRMO FUT3 ZMYM5	4.66e-05	200	189	9	5772_DN
Drug	cetiedil	HEXA NOX5 NAGLU	6.47e-05	10	189	3	CID000066383
Drug	AC1MQWF5	FUT3 FUT4 FUT6	6.47e-05	10	189	3	CID003458642
Drug	AC1MIWV3	HEXA HEXB NAGLU	6.47e-05	10	189	3	CID003081404
Drug	isobutyl alcohol	CHRNA2 CHRNB4	6.85e-05	2	189	2	ctd:C040507
Drug	PNP-GlcNAc-6-SO4	HEXA HEXB	6.85e-05	2	189	2	CID000133365
Drug	crotonyl alcohol	CHRNA2 CHRNB4	6.85e-05	2	189	2	ctd:C007153
Drug	N-acetyllactosamine	HEXA HEXB XYLT2 CHPF SNAI1 FUT3 FUT4 FUT6	7.04e-05	164	189	8	CID000000245
Disease	autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology)	STRC STRCP1	3.91e-05	2	185	2	DOID:0110471 (implicated_via_orthology)
Disease	alpha-L-iduronidase measurement	DGKQ FAM53A IDUA	1.55e-04	17	185	3	EFO_0020139
Disease	anorectal malformation	RTEL1 GAS6 CSMD2	2.18e-04	19	185	3	MONDO_0019938
Disease	cancer antigen 19.9 measurement	FUT3 FUT6	2.33e-04	4	185	2	EFO_0010584
Disease	polyp of gallbladder	FUT3 FUT6	2.33e-04	4	185	2	MONDO_0021416
Disease	Weill-Marchesani syndrome	ADAMTS17 LTBP2	2.33e-04	4	185	2	cv:C0265313
Disease	alpha-(1;3)-fucosyltransferase 5 measurement	FUT3 FUT6	2.33e-04	4	185	2	EFO_0021979
Disease	Weill-Marchesani syndrome (is_implicated_in)	ADAMTS17 LTBP2	2.33e-04	4	185	2	DOID:0050475 (is_implicated_in)
Disease	Profound Mental Retardation	HEXA LAMA1 NAGLU DCC KIF7 MAN1B1	2.52e-04	139	185	6	C0020796
Disease	Mental Retardation, Psychosocial	HEXA LAMA1 NAGLU DCC KIF7 MAN1B1	2.52e-04	139	185	6	C0025363
Disease	Mental deficiency	HEXA LAMA1 NAGLU DCC KIF7 MAN1B1	2.52e-04	139	185	6	C0917816
Disease	Sclerocystic Ovaries	SRD5A1 STAR FOXP3 ADGRD2 CDH15 ZMYM5	3.05e-04	144	185	6	C1136382
Disease	Polycystic Ovary Syndrome	SRD5A1 STAR FOXP3 ADGRD2 CDH15 ZMYM5	3.05e-04	144	185	6	C0032460
Disease	desmoglein-2 measurement	FUT3 FUT6	3.86e-04	5	185	2	EFO_0020322
Disease	level of V-set and immunoglobulin domain-containing protein 2 in blood serum	FUT3 FUT6	3.86e-04	5	185	2	OBA_2044774
Disease	gastroesophageal reflux disease	DCC ADAMTS17 SDK1 MON1A ABHD5	4.47e-04	101	185	5	EFO_0003948
Disease	lactoperoxidase measurement	FUT3 FUT6	5.77e-04	6	185	2	EFO_0020525
Disease	alkaline phosphatase measurement	GAS6 PHLDB1 PKD2 NTN5 PLA2G6 KIF17 USP43 FBXW4 HIVEP3 EDEM3 MACF1 LTBP2 FUT3 FUT6 ERCC6L2-AS1 HDLBP	6.97e-04	1015	185	16	EFO_0004533
Disease	lithostathine-1-alpha measurement	FUT3 FUT6	8.04e-04	7	185	2	EFO_0801083
Disease	galactoside 3(4)-L-fucosyltransferase measurement	FUT3 FUT6	8.04e-04	7	185	2	EFO_0021853
Disease	alpha-(1,3)-fucosyltransferase 5 measurement	FUT3 FUT6	8.04e-04	7	185	2	EFO_0020136
Disease	metabolite measurement	GABRR1 UGT3A1 DCC CHRNB4 AJAP1 CACTIN-AS1 MRI1 RIMBP2 ASB2 FUT3 FUT6	8.65e-04	560	185	11	EFO_0004725
Disease	vitamin B12 measurement	SDK1 FUT3 FUT6	1.05e-03	32	185	3	EFO_0004620
Disease	renin measurement	CNTN2 PLEKHA6	1.07e-03	8	185	2	EFO_0010616
Disease	prostate cancer (implicated_via_orthology)	SRD5A1 MEP1A HDLBP	1.15e-03	33	185	3	DOID:10283 (implicated_via_orthology)
Disease	lung cancer (is_implicated_in)	DAB2IP RTEL1 CHRNB4 POT1	1.22e-03	74	185	4	DOID:1324 (is_implicated_in)
Disease	orthostatic hypotension	STAR CD163L1	1.37e-03	9	185	2	EFO_0005252
Disease	hypothyroidism (biomarker_via_orthology)	SRD5A1 STAR FOXP3 NCOA1	1.63e-03	80	185	4	DOID:1459 (biomarker_via_orthology)
Disease	Colorectal Carcinoma	LAMA1 OBSCN DCC ADARB2 UHRF2 COL7A1 FN1 FPGS HIVEP3 SLCO2A1 DCHS1 DIP2C	1.67e-03	702	185	12	C0009402
Disease	cortical thickness	FAM178B LAMA1 MBD6 DNAAF3 ZNF469 PHLDB1 DMRT3 MAST4 PLEKHA7 PLXNA2 NPR2 TRIOBP IDUA MACF1 ERCC6L2-AS1 EPHA4	1.81e-03	1113	185	16	EFO_0004840
Disease	papillary thyroid carcinoma	TRMO SOWAHB	2.48e-03	12	185	2	EFO_0000641
Disease	nevus count, cutaneous melanoma	RTEL1 PLA2G6 POT1 CDH15	2.61e-03	91	185	4	EFO_0000389, EFO_0004632
Disease	candidiasis (implicated_via_orthology)	FUT3 FUT4 FUT6	2.66e-03	44	185	3	DOID:1508 (implicated_via_orthology)
Disease	Connective Tissue Diseases	ZNF469 PKD2	2.91e-03	13	185	2	C0009782
Disease	smoking status measurement, systolic blood pressure	ZNF831 ADARB2 AJAP1 SIPA1 AP5B1	3.09e-03	156	185	5	EFO_0006335, EFO_0006527
Disease	neuroimaging measurement	NAGLU DCC MBD6 DNAAF3 ZNF469 DMRT3 MAST4 MAP3K11 PLEKHA7 PLXNA2 PTPN21 IDUA PABPC3 MACF1 EPHA4	3.14e-03	1069	185	15	EFO_0004346
Disease	polycystic kidney disease (implicated_via_orthology)	XYLT2 PKD2	3.39e-03	14	185	2	DOID:0080322 (implicated_via_orthology)
Disease	cancer biomarker measurement	FUT3 FUT6	3.89e-03	15	185	2	EFO_0005127
Disease	chenodeoxycholate measurement	DCC ERCC6L2-AS1	3.89e-03	15	185	2	EFO_0010471
Disease	Schizophrenia	A1BG GABRR1 LAMA1 DCC CSMD2 PLA2G6 DNM1 KIF17 PLXNA2 MCHR1 PLEKHA6 PTPN21 PCNT	3.93e-03	883	185	13	C0036341
Disease	Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive	STRC OTOA TRIOBP	4.05e-03	51	185	3	cv:CN043650
Disease	PR interval	OBSCN DNAAF3 ZNF469 HCFC2 EML4 SKI HIVEP3 MACF1 SLC2A11	4.19e-03	495	185	9	EFO_0004462
Disease	galectin-3 measurement	FUT3 FUT6	4.43e-03	16	185	2	EFO_0008137
Disease	gout, hyperuricemia	PKD2 FAM53A	4.43e-03	16	185	2	EFO_0004274, EFO_0009104
Disease	waist-hip ratio	NAGLU DGKQ MEP1A MAST4 PIK3C2B DLAT CNTN2 NAT14 FN1 FAM53A SIPA1 ZNF446 SH2B1 ABHD5 LTBP2 ANO3	4.64e-03	1226	185	16	EFO_0004343
Disease	colorectal cancer	RTEL1 SLC27A5 LAMA5 SLCO2A1 MACF1 FUT3 FUT6 ANO3 CDH15 PCNT	4.99e-03	604	185	10	MONDO_0005575
Disease	Ciliopathies	DNAAF3 PKD2 TMEM231 KIF7	5.15e-03	110	185	4	C4277690
Disease	polyp of colon	PIK3C2B LAMA5 CDH15	5.27e-03	56	185	3	MONDO_0021400
Disease	idiopathic pulmonary fibrosis	RTEL1 FUT3 FUT6	5.53e-03	57	185	3	EFO_0000768
Disease	Dystonia, Paroxysmal	DLAT ANO3	5.60e-03	18	185	2	C0393588
Disease	Alzheimer disease, age at onset	LAMA1 TMEM132C TRMO DCHS1 ANO3 ERCC6L2-AS1 EPHA4	6.10e-03	343	185	7	EFO_0004847, MONDO_0004975
Disease	neck circumference	AJAP1 GALNTL6	6.23e-03	19	185	2	EFO_0011043
Disease	response to methotrexate, neurotoxicity	DAB2IP MACF1	6.23e-03	19	185	2	EFO_0011057, GO_0031427

Protein segments in the cluster

Peptide	Gene	Start	Entry
PAWASRRPLQAQVVL	nan	11	Q6ZRM9
WDIVALPGRRTVNPQ	CHRNB4	201	P30926
AGSTPVAIPRDFWLR	CHRNB4	401	P30926
VRAPVGVAGLISPWN	ALDH8A1	141	Q9H2A2
TVWEALTNTRPGARP	ANKRD13D	506	Q6ZTN6
ITIWDGPQQTAPRLG	CSMD2	2236	Q7Z408
IPVREVPVAGVDRWF	BAIAP3	351	O94812
APEVSRWAGPIIDVL	ASB2	546	Q96Q27
FRSGQPARVPAPVWS	AJAP1	66	Q9UKB5
EATPEAWVIRALPRA	DGKQ	381	P52824
NRWARPVPNTSDVVI	CHRNA2	71	Q15822
RVFTARISWLLGQPP	C1orf74	201	Q96LT6
PPAESVARRVGWTVR	APBB1	676	O00213
AWPRVGPAVALAVEA	NPR2	41	P20594
LLAVERTGQRPLWAP	CISH	11	Q9NSE2
SPVWVPESRRGAQLA	DNHD1	4421	Q96M86
WVSPQQELLRAPGSR	AMIGO3	311	Q86WK7
GVVNSPAVLRPIWLD	CD163L1	206	Q9NR16
VEEARLAWPVLVGPQ	CACTIN-AS1	156	Q8N1I8
AATSRPERVWPDGVI	BMP1	121	P13497
PLPAATVGRWAAEQR	CCDC157	266	Q569K6
PDPWAGQAVRAEQLR	ATG2A	656	Q2TAZ0
AAADVEVVLPWRVRP	ADAMTS17	31	Q8TE56
PGSRCPVQEQRARWE	ARHGEF39	6	Q8N4T4
WGPAQIRAVLGAVPR	NAGLU	361	P54802
PAEQASRPWTQPRGA	ZFYVE19	386	Q96K21
SRPWTQPRGAEPEAQ	ZFYVE19	391	Q96K21
TQWRRPLPARATDIG	ANO3	796	Q9BYT9
PVRGPSAVQTWDGVL	ADARB2	531	Q9NS39
ITGLQTRTQPGRPDW	NOX5	706	Q96PH1
PRPQLRATWSGAVLA	A1BG	401	P04217
LPAAIIDRGISPRAW	OTOA	706	Q7RTW8
ASPDWVGPSTRLRQQ	DAB2IP	956	Q5VWQ8
FEAGPPWRALTVRAE	DCHS1	1396	Q96JQ0
RAVIVSWQPPLEANG	DCC	961	P43146
PVATSVPIGWQRCVR	MBD6	16	Q96DN6
LLNWRRVSSFTGPVP	HCFC2	6	Q9Y5Z7
ATGNPRPIVSWSRLD	IGDCC3	261	Q8IVU1
RRAPLAAGTWRSAPV	MAGED1	266	Q9Y5V3
AWRRAAVAVTAAPGP	NFS1	6	Q9Y697
PGINVASLEWVSREP	FOXP3	151	Q9BZS1
PGRNVSVSWRPRAEE	KTI12	126	Q96EK9
EPVPGERWEAARAQR	DYNLT4	111	Q5JR98
SWLQVQSVPAGRRSP	DNM1	761	Q05193
RPQAALIWSREINGP	GAB3	251	Q8WWW8
PADAWRAEAALPVRA	FUT4	111	P22083
QEAFRPGAIVSPWRL	NCR3LG1	86	Q68D85
SPVPQRARWRLVAAT	EDEM3	11	Q9BZQ6
GGTSRAQVPPLSWIR	BNIPL	261	Q7Z465
VRWSPVRPLVFAAAS	DYNC2I2	441	Q96EX3
SVALAWLEPDRPNGV	EPHA4	456	P54764
PRARLVVPVAVAAWG	NAT14	161	Q8WUY8
PRVQRIEPEWSIASG	PLXNA2	1041	O75051
RWTALQEVPGTPRVT	DLAT	21	P10515
AVSVLAGPRWADPQI	NUDT9	101	Q9BW91
PWRGAVALAAEVPER	PEAK3	246	Q6ZS72
PSAEGPQRNTRLGWI	CES5A	26	Q6NT32
ELTDQAWLPAGVRVP	NOL6	126	Q9H6R4
RQVPPATASEWRLAQ	KIF7	691	Q2M1P5
EWIPVLQRPSRTAAV	MACF1	826	O94854
ALVSVPRAQAVWLGR	LCN6	11	P62502
ENPPASVLAVLRNRW	MIGA2	446	Q7L4E1
GVPVALRTDDWAVLP	AP5B1	851	Q2VPB7
GEPFVLNPGTWALRV	LAMA5	986	O15230
VQAPRWGNPRALSFV	OAS1	121	P00973
RQEEGTRAPWRTPAA	H1-7	136	Q75WM6
AATQRAVTPWPRGRL	ISCA2	11	Q86U28
AAGAAPPELQWLRAQ	PCNT	1911	O95613
PVGAEAWARRVPQPA	MEF2B	256	Q02080
NITFWERIPTSPAGR	LRRC70	451	Q7Z2Q7
PQRTVISWRGAVIEP	MAN1B1	201	Q9UKM7
QIARLRPSPRWTAQG	PABPC3	421	Q9H361
PVRTTAEAQRPWRDG	PTPN21	776	Q16825
QRRVPEALGWVTTPL	PIK3C2B	726	O00750
GVNVTLRCRAPQPAW	OSCAR	46	Q8IYS5
PELRWTRNATALAPG	OBSCN	2016	Q5VST9
PPWVRQRAVTGTFCA	MON1A	71	Q86VX9
QDFWIGRVHRGAPPI	B3GNT5	216	Q9BYG0
TTEVPSRLPWAARAG	GSN-AS1	136	Q9NRJ2
VSFWIDRRAVPARVP	GABRR1	301	P24046
AVGRPEPTVTWRQLR	IGLON5	156	A6NGN9
FPRRAQGPTWRSLEV	SLC2A11	476	Q9BYW1
VWGNALLRPPVAAFV	DNAAF3	116	Q8N9W5
RRALAAQLPVLPWSE	FAHD2B	81	Q6P2I3
AALRWTAEPQPGALQ	DMRT3	131	Q9NQL9
SIVVRWSRPQAPITG	FN1	826	P02751
WAPDLRAVPLSVALV	GAS6	526	Q14393
PSIALRQPEATGWRR	ERCC6L2-AS1	11	Q8WZB0
SELIPWAVQNGRRAP	COQ4	216	Q9Y3A0
RGEQLGVVTNWPPSL	DIP2C	306	Q9Y2E4
IVRITWSNPPAQGAR	GOT1	291	P17174
SIWNVGTPSRGPLQR	ATRNL1	341	Q5VV63
PTVRWLRNGEPLASQ	CNTN2	356	Q02246
RNALEAWAVPVVLGP	FUT6	261	P51993
RPQGPADAWRAAVLI	IDUA	426	P35475
GPAERQPLRVVTDTW	LTBP2	766	Q14767
LSPRLQDQGSGVRPW	FBXO24	86	O75426
RESAARPAAGPALWR	FBXW4	16	P57775
RAPAAWAPASVLLER	MAST4	76	O15021
RLPQPAWVEGSSARL	MCHR1	46	Q99705
VAARRGLSAWPVPQE	FPGS	26	Q05932
ADQWTALPRLPTARA	KLHDC8A	56	Q8IYD2
ATELPGQRVRVSWSP	COL7A1	516	Q02388
ATRVRVAWGPVPGAS	COL7A1	611	Q02388
GRPLQPHVRVWDSVT	EML4	336	Q9HC35
TNLTPRLWPRASAVG	HEXB	496	P07686
VVLSWVRPFDGNSPI	SDK1	686	Q7Z5N4
RLQWVPGSDGASPIR	SDK1	1496	Q7Z5N4
RDLPGSPNWVARFTI	CDH15	286	P55291
RADAAGLAWPPTRRA	PERM1	451	Q5SV97
AGRRVPPHVLVNWAV	MAP3K11	206	Q16584
AATGLPPRVWAVVDL	NEURL4	181	Q96JN8
NPPNWSRTVVRDVRL	NOA1	301	Q8NC60
LRLWGIPDQARVAPS	CMTR1	536	Q8N1G2
AWLVLRAPRGGAQTP	DHRS13	251	Q6UX07
PEVTGDARSAFWPLR	nan	21	A6NNC1
VASGPRPWAEQLRAR	PKN3	91	Q6P5Z2
VRTAEPGVWLEAQAP	KIF17	686	Q9P2E2
NTNLVPRLWPRAGAV	HEXA	466	P06865
GLVALWTSRAGRPPQ	GRIN3B	186	O60391
EAWAVPVVLGPSRSN	FUT3	266	P21217
PPAAWGEIRNVAANL	GALNTL6	451	Q49A17
AFADARAQLPSWVRP	RTEL1	716	Q9NZ71
PSPNFSVVLGIRWLR	RTL1	496	A6NKG5
QAGVTPATIRVSWRP	RIMBP2	496	O15034
VRGILQWRGTVDPPS	SH2B1	166	Q9NRF2
QRPVPWDVRAVSVEA	TMEM132A	116	Q24JP5
LRLDGNVVIWLPSRP	TMEM132C	286	Q8N3T6
RSPRWPVVVAEGEGQ	TMEM132C	751	Q8N3T6
QVDPERSSRLPWAVA	SCCPDH	31	Q8NBX0
VQAALARPSPRWGLA	TGFBR3L	91	H3BV60
PVRRGDQDAWVPRAD	NTN5	401	Q8WTR8
VNSSGPDWVTVIPRR	NXPE3	291	Q969Y0
DRRWRSPAQGNLPSV	RIMBP3	1526	Q9UFD9
GAQDWRRADSLPRPQ	PROSER2	391	Q86WR7
SLVNGVPWPQEATRR	NCOA1	176	Q15788
SREAPAQRWVGVVGP	FAM178B	126	Q8IXR5
AANAPRPGNWILERS	LAMA1	126	P25391
PAINDTVIWDRPSRV	MEP1A	536	Q16819
GTRTPFPSWRVLIQD	POT1	186	Q9NUX5
AIRRNPNVPVVVRGW	PLEKHA7	156	Q6IQ23
LVWGVRAAPGARVAA	SIPA1	581	Q96FS4
TPAWVQTGRPPARAR	SHISA8	111	B8ZZ34
VRIAAPGIGVWNPAF	MRI1	311	Q9BV20
CISRQRVWGVPIPVF	IARS2	521	Q9NSE4
PPAQPSDQLVWRAAR	PLA2G6	621	O60733
VPEARDQGPIRAWSV	SOWAHB	316	A6NEL2
PSSGGPRVVERQWEA	KBTBD11	66	O94819
QEQLWPRARPEAAGS	SKI	706	P12755
GAVLSPRELRVWAPL	STRC	986	Q7RTU9
EVPWASIALRPTQGD	TRIOBP	931	Q9H2D6
GAVPQALVAWRALGP	ROBO4	686	Q8WZ75
STPVGPWDQAVQRRS	SSH3	16	Q8TE77
DRPIPVWIRALGAAL	ABHD5	191	Q8WTS1
SRLRDPVWVGQREAP	ADGRD2	91	Q7Z7M1
GSRAQPRRWPVQVLS	ARL6IP6	96	Q8N6S5
RFPGARVPWLSVQTA	CHPF	576	Q8IZ52
TAAVNLVPGDPRWIG	SLCO2A1	241	Q92959
GAPEVLVSAPRSLVW	POGLUT3	21	Q7Z4H8
PGIPVGSTWRFRVQV	UHRF2	451	Q96PU4
GRQDATVWIPSPSRQ	PLEKHA6	416	Q9Y2H5
TWPQTAGRVVARTPA	MRPS11	16	P82912
PIAWASLRLQESPRV	SNAI1	71	O95863
ATSGIDPVVRLWNPR	WDTC1	596	Q8N5D0
SQPLSPAQRLVGWID	UGT3A1	446	Q6NUS8
RADGAPRSVVPAWVT	TRMO	316	Q9BU70
GPPFLIREDRAVSWA	USP43	416	Q70EL4
NAPAPRRRSVAWPAA	nan	116	Q6ZSR3
WRETRVLQASQAGPP	ZFP57	76	Q9NU63
SPLAPVSQQGWRSIR	TEP1	886	Q99973
PLARIVSWSQVGVEP	ACAT2	276	Q9BWD1
REPPAQAVRFLPWAT	SPEG	631	Q15772
VPADLRAGITWRSPA	SLC27A5	276	Q9Y2P5
GGPTPSTWINQVRRR	STAR	41	P49675
GRRAAQSWSPRLESP	HIVEP3	2321	Q5T1R4
VAARPPGFQVREAIW	SLAMF8	36	Q9P0V8
VAESPRPRRWAAHGA	PHLDB1	486	Q86UU1
EGQPPRVAWAERLVR	PKD2	181	Q13563
PLGPETRVSVVWVER	RALGAPB	1336	Q86X10
WEQGSRAAPLQEAVP	ARHGAP8	426	P85298
GLRAVRADAALPVWP	nan	161	Q3C1V9
GTLPPEIQAWVRGQR	ZNF446	76	Q9NWS9
SLTAPRGREAWLVPV	ZNF469	1836	Q96JG9
WIRPALLSGPVAANV	SLC30A6	336	Q6NXT4
VVLSADPGTWPRILN	ZMYM5	516	Q9UJ78
ARRLWEAVSGAQPVG	ZNF346	41	Q9UL40
PIWLVGRAADAPFVI	TMEM231	231	Q9H6L2
PARAAWVVQELPSLA	SRD5A1	51	P18405
GAVLSPRELRVWAPL	STRCP1	986	A6NGW2
APSRGFVVRDAPWTA	HDLBP	1221	Q00341
PTPIFAGGANDRWVR	WSB1	301	Q9Y6I7
RARLSGDVLNPWVPN	ZNF831	1086	Q5JPB2
ELVLPPRISRVNGWS	ZDHHC11B	21	P0C7U3
PPARLSWTQRGQVLS	SIGLEC10	386	Q96LC7
RSPEAAGVQDPSLRW	UCN	26	P55089
LGPLDEPVAVQRWAR	XYLT2	666	Q9H1B5
EPVAVQRWARGPNLT	XYLT2	671	Q9H1B5
RNTSWGVVQEPPGRA	TLE6	226	Q9H808
DAQVALTLRPGWPRG	TTC31	361	Q49AM3
EARVPAQSESVRRPW	VASP	296	P50552
PRGTGANAPWVLVAV	UNQ6493/PRO21345	6	Q6UXR8
RQGSPGAVLPRSAVW	FAM53A	161	Q6NSI3
SQPEALSRILVPAAW	NECAB2	366	Q7Z6G3
NWTRLDGPLPSGVRV	NECTIN4	281	Q96NY8